Skip to main content
. 2023;24(1):61–67. doi: 10.31557/APJCP.2023.24.1.61

Figure 1.

Figure 1

The Inclusion and Exclusion Criteria, and Flowchart of Patient Allocation in this Study. ECOG PS, Eastern Cooperative Oncology Group performance status; F/U, follow-up; IBD, inflammatory bowel disease; NSAIDs, nonsteroidal anti-inflammatory drugs; PMH, past medical history